The Collaborative Ocular Melanoma Study: an overview

Cancer Control : Journal of the Moffitt Cancer Center
Curtis E Margo

Abstract

The Collaborative Ocular Melanoma Study (COMS) is a 3-arm study that includes two multicenter randomized clinical trials designed to compare the effectiveness of brachytherapy to enucleation for treatment of medium-size choroidal melanomas, and the effectiveness of enucleation with and without preoperative external-beam radiotherapy for large choroidal melanomas. The third arm is an observational study of small choroidal melanomas. Patient accrual ran from 1987 to 1998. A review of COMS published reports was conducted. There is no difference in 5-year all-cause mortality for large- and medium-size choroidal melanomas with COMS-designated treatments. Preoperative radiation for large choroidal melanomas does not improve survival. The accuracy of the clinical diagnosis of choroidal melanoma is excellent. Data from the trials are still being collected and analyzed, but primary outcomes will unlikely change significantly in the future. Similar rates of mortality after treatment with enucleation and brachytherapy shift the emphasis of selection of therapy to secondary outcomes such as preservation of vision. The findings highlight the need to better understand the biological mechanisms and timing of hematogenous dissemination to achi...Continue Reading

References

Feb 1, 1992·Archives of Ophthalmology·J A MarkowitzA P Schachat
Apr 1, 1992·Klinische Monatsblätter für Augenheilkunde·R GuthoffJ U Prause
Apr 1, 1991·Archives of Ophthalmology·M G Edwards, A P Schachat
May 15, 1990·American Journal of Ophthalmology·J J AugsburgerL W Brady
Mar 1, 1989·Ophthalmology·U L KarlssonR Woodleigh
Jan 1, 1988·Survey of Ophthalmology·K M EganD M Albert
Jul 1, 1988·The British Journal of Ophthalmology·K S AdamsL Polivogianis
Nov 1, 1986·The British Journal of Ophthalmology·P K Lommatzsch
Jan 1, 1984·Archives of Ophthalmology·C E Margo, I W McLean
Jun 1, 1980·Ophthalmology·S Packer, M Rotman
Mar 1, 1997·Archives of Ophthalmology·C E Margo
Jun 17, 1998·Ophthalmology·C E MargoK Billiris
Jun 1, 2001·Controlled Clinical Trials·C S MoyUNKNOWN Collaborative Ocular Melanoma Study Group, prepared by COMS Mortality Coding Committee
Jul 27, 2001·Archives of Ophthalmology·M Diener-WestUNKNOWN Collaborative Ocular Melanoma Study Group
Jan 30, 2002·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael Thun
Jun 20, 2003·Cancer Causes & Control : CCC·Peter D InskipJoseph F Fraumeni
Jul 2, 2003·American Journal of Ophthalmology·Bradley R StraatsmaUNKNOWN Collaborative Ocular Melanoma Study Group
Jul 2, 2003·American Journal of Ophthalmology·Dennis M Robertson
Jul 16, 2003·Archives of Ophthalmology·Michele MeliaUNKNOWN Collaborative Ocular Melanoma Study-Quality Of Life Study Group
Oct 28, 2003·Investigative Ophthalmology & Visual Science·Emma KujalaTero Kivelä
Nov 5, 2003·Ophthalmology·Ilkka PuusaariTero Kivelä

❮ Previous
Next ❯

Citations

Nov 3, 2009·European Journal of Ophthalmology·Giuseppe QuerquesNicola Delle Noci
Sep 9, 2015·The British Journal of Ophthalmology·Konstantinos BalaskasMandeep S Sagoo
May 24, 2016·Vestnik oftalmologii·A F BrovkinaI P Chesalin
Nov 30, 2016·International Ophthalmology Clinics·Ronald W MilamAnthony B Daniels
Jul 13, 2018·Acta Ophthalmologica·Kalpana RoseChristopher Hudson
Nov 27, 2019·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Henrietta WangMichael Kalloniatis
Jul 10, 2020·Clinical & Experimental Ophthalmology·Li-Anne S Lim, Michael E Giblin
Oct 1, 2013·Journal of Oncology·Søren K O Abildgaard, Henrik Vorum
Jan 1, 2011·Retinal Cases & Brief Reports·Carolyn ChenRajiv Anand
Feb 23, 2013·Current Opinion in Ophthalmology·Ana AlmeidaCarol L Shields
Aug 30, 2017·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·J M MorL M Heindl
Sep 1, 2018·Vestnik oftalmologii·A F Brovkina
May 4, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Ciro García-ÁlvarezYerena Muiños
Feb 17, 2009·Cancer Investigation·Andrew S KennedyWilliam A Dezarn
May 22, 2019·Cancers·Sara Silvia ViolantiPaolo Perri
Apr 2, 2020·Korean Journal of Ophthalmology : KJO·Tae Hwan KimJin Sook Yoon
Apr 9, 2014·Rare Tumors·Elizabeth Trice Loggers, Holly G Prigerson
Jun 1, 2017·Asia-Pacific Journal of Ophthalmology·Mehmet DogrusözBertil Damato
May 16, 2012·Journal of Applied Clinical Medical Physics·Hualin ZhangYujin Qi
Oct 21, 2015·Melanoma Research·Kirsten Eibl-LindnerAlexander Muacevic
May 27, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Els R KoomenJan-Willem W Coebergh
Apr 9, 2010·Melanoma Research·Michelle D WilliamsPatrick Hwu
Apr 15, 2021·Progress in Retinal and Eye Research·Thomas StrubCorine Bertolotto
May 23, 2012·World Journal of Surgical Oncology·Sara LanglaisLucas Sideris
Aug 31, 2021·Curēus·Ahmad JiblawiKhaled Jiblawi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.